✦ LIBER ✦

Is it time for a reassessment of prognostic features in B-cell chronic lymphocytic leukemia?

✍ Scribed by S. Molica

Publisher: Springer
Year: 1999
Tongue: English
Weight: 161 KB
Volume: 41
Category: Article
ISSN: 1269-3286
DOI: 10.1007/s00282-999-0087-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of TCL-1 as a potential progn

Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia

✍ Rebekah L. Browning; Susan M. Geyer; Amy J. Johnson; Diane F. Jelinek; Renee C. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 208 KB

TCL-1 expression is variable in CLL, and no study has examined its association with treatment response. We measured TCL-1 protein in CLL cells from 51 patients who then received pentostatin, cyclophosphamide, and rituximab. TCL-1 expression did not correlate with any pre-treatment characteristics. L

Apoptotic effect of fludarabine is indep

Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia

✍ K. L. Silva; D. V. Vasconcellos; E. D. de Paula Castro; A. M. Coelho; R. Linden; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 446 KB

Increased serum BAFF (B-cell activating

Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia

✍ Stefano Molica; Giovanna Digiesi; Francesca Mauro; Rosanna Mirabelli; Giovanna C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 121 KB

CD38 as a prognostic factor in B cell ch

CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): Comparison of three approaches to analyze its expression

✍ Joke G. Boonstra; Kirsten van Lom; Anton W. Langerak; Wilfried J. Graveland; Pet 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

## Abstract ## Background: Increased CD38 expression by leukemic cells has been suggested as an adverse prognostic factor in B‐CLL. Several approaches have been proposed to quantify its level of expression by flow cytometry. ## Methods: We compared the use of (i) the percentage of CD38 positive

A scoring system based on the expression

A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia

✍ Antonella Zucchetto; Riccardo Bomben; Michele Dal Bo; Paolo Sonego; Paola Nanni; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 1 views

## Abstract We have previously identified 12 surface antigens whose differential expression represented the signature of B‐cell chronic lymphocytic leukemia (B‐CLL) subsets with different prognosis. In the present study, expression data for these antigens, as determined in 137 B‐CLL cases, all with

2-Chlorodeoxyadenosine treatment in non-

2-Chlorodeoxyadenosine treatment in non-Hodgkin's Lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience

✍ M. Brugiatelli; B. Holowiecka; A. Dmoszynska; O. Krieger; A. Planinc-Peraica; B. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 165 KB